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Abstract: Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are non-invasive 
brain stimulation techniques that, by means of magnetic fields and low intensity electrical current, respectively, aim to in-
terefere with and modulate cortical excitability, at the level of dorsolateral prefrontal cortex, in patients with major de-
pression and poor response to standard antidepressants. While the clinical efficacy of TMS in major depression has been 
extensively investigated over the last 10 years, tDCS has attracted research interest only in the last years, with fewer ran-
domized clinical trials (RCTs) in the field. Nevertheless, in spite of the different rationale and mechanism of action of the 
two techniques, tDCS recent acquisitions, in relation to the treatment of major depression, seem to parallel those previ-
ously obtained with TMS, in terms of treatment duration to achieve optimal benefit and patient's history of drug-
resistance. After briefly introducing the two techniques, the article examines possible common pathways of clinical use 
for TMS and tDCS, emerging from recent RCTs and likely orienting future investigation with non invasive brain stimula-
tion for the treatment of major depression. 
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Within transcranial brain stimulation techniques, both 
transcranial magnetic stimulation (TMS) and transcranial 
direct current stimulation (tDCS) represent non-invasive 
interventions, increasingly used in psychiatric research and 
clinical practice, to focally and selectively stimulate the 
dorso-lateral prefrontal cortex (DLPFC) in patients with ma-
jor depression and poor response to standard antidepressant 
treatments. 
While TMS utilizes coil-generated magnetic fields to 
penetrate the brain and, then, convert in electric current 
modulating cortical excitability, in tDCS, weak electric cur-
rents (1-2 mA) are directly applied to the scalp with the same 
purpose, by means of two electrodes: the anode (where the 
current enters), positioned over the left DLPFC, and the 
cathode (generally on the right DLPFC, where the current 
flows out). 
While magnetic impulses can directly interfere with po-
larization process of cortical neurons and strengthen synaptic 
connections through mechanisms of long-term potentiation 
and depression, tDCS effects are supposed to be more ori-
ented toward modulation of neurotransmitter systems and 
promotion of brain derived neurotrophic factor–dependent 
synaptic plasticity, even though tDCS induced changes in 
resting membrane potential, spontaneous neuronal firing 
rates, cerebral blood flow and metabolism as well as increase 
in myo-inositol brain content have been reported [1-3].  
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In spite of a different rationale and peculiar mechanisms 
of action, both TMS and tDCS are aimed to restore the func-
tional balance between the 2 brain hemispheres, which is 
supposed to be altered in major depression [4]. Current 
pathophysiological models, in fact, converge in suggesting 
that two major groups of brain regions - a "dorsal" and "ven-
tral" network - account for the formation of the varied symp-
toms of depressive illness [4]. Within this theoretical frame-
work, depression is hypothesized to involve concurrent hy-
poactivation of dorsal prefrontal regions and hyperactivation 
of ventral prefrontal regions, particularly in the left hemi-
sphere [5]. Symptom remission is, therefore: supposed to 
require facilitation of hypoactive dorsal brain regions and 
inhibition of hyperactive ventral areas, which is actually 
what transcranial stimulation techniques aim to obtain [4, 5]. 
With respect to clinical use of transcranial stimulation 
techniques, compared to tDCS, repetitive TMS has been 
more extensively investigated in the field of major depres-
sion, over the last years, in terms of large randomized, sham 
controlled trials yelding meta-analyses [6], guidelines rec-
ommendations [7] as well as, in some countries, specific 
approval by local regulatory agencies. Taken as a whole, the 
aforementioned studies have allowed at least two important 
acquisitions, aimed to maximize treatment response and bet-
ter characterize TMS candidate: 1) longer duration of treat-
ment (i.e., more tms sessions) produce higher response and 
remission rates and 2) higher treatment resistance level to 
previous treatments reduces tms response. Therefore, even 
though other stimulation parameters still need to be further 
investigated (e.g., tms as monotherapy or augmentative 
treatment, need for and schedule of maintenance sessions 
after acute treatment, efficacy in unipolar vs bipolar depres-
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sion, etc.), it is currently well established that the best candi-
date for TMS response should be treated for not less than 3/4 
weeks and should not be a highly treatment resistant subject.  
With respect to tDCS, a more limited number of sham-
controlled studies has been published to date, yelding room 
for only two meta-analyses [8, 9], but no specific treatment 
guideline, in the field of major depression. In such perspec-
tive, however, the recently published, largest controlled trial 
(published after the aforementioned meta-analyses) showed 
that tDCS was superior to placebo/sham tDCS over a six-
week treatment course, as well as comparable efficacy to 
sertraline [10]. Of note, authors found that baseline severity 
and treatment resistance to more than 1 failed antidepressant 
trial were associated with a lower response. Previously, an-
other sham-controlled, randomized trial found an increased 
number of responders after 6 weeks of treatment compared 
to 3 weeks, suggesting that antidepressant effects might be 
enhanced with longer treatment [11]. Taken as a whole, 
tDCS recent results in terms of duration of treatment and 
baseline level of treatment resistance, in relation to outcome, 
seem to parallel previous, large multicenter TMS studies [12, 
13], supporting the perspective of a similar profile for candi-
date choice to transcranial non-invasive stimulation tech-
niques. While further studies are required to confirm such 
aspects, the debate as to which technique to offer patients 
[14] should also start to consider more specifically tolerabil-
ity-related issues and procedure-related costs as well as other 
clinical features that may orient clinician’s choice.  
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